Ticker
ENTOCompany Name
ENTERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 2.92M | $ 1.73M | $ 490.64K | $ 0 | -75.98% |
3/31/2025 | $ 2.05M | $ 2.62M | $ 281.43K | $ 0 | -141.63% |
12/31/2024 | $ 1.95M | $ 6.23M | $ -644.58K | $ 0 | -285.64% |
9/30/2024 | $ 3M | $ 10.58M | $ -612.78K | $ 0 | -332.93% |
6/30/2024 | $ 3.23M | $ 14.39M | $ -588.7K | $ 0 | -427.07% |
3/31/2024 | $ 7.35M | $ 15.66M | $ -606.4K | $ 0 | -204.84% |
12/31/2023 | $ 8.87M | $ 15.83M | $ -603.49K | $ 0 | -171.65% |
9/30/2023 | $ 3.75M | $ 18.86M | $ -603.49K | $ 0 | -486.37% |
6/30/2023 | $ 3.02M | $ 20.69M | $ -611.92K | $ 0 | -664.58% |
3/31/2023 | $ 5.02M | $ 18.85M | $ -625.87K | $ 0 | -362.68% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ENTERO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 973.08K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 4.17M ]) / Market Cap [ $ 21.27M ]
(=) Shareholder Yield [ -24.17% ]
Minimum
Jun 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |